James Barry
Insider
First SEC filing: May 8, 2024 · Latest: May 8, 2024
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-214,326
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | M | 1,056 | · | · | 2,495 Direct | +73.38% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | F | 470 | $386.11 | $181,472 | 2,025 Direct | -18.84% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 6, 2026 | BIO | M | 1,056 | · | · | 2,112 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 1,808 Direct | +131.50% | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | F | 369 | $386.11 | $142,475 | 1,439 Direct | -20.41% | Disposed | -4.4% (price as of 2026-10-02) |
| Sept. 5, 2026 | BIO | M | 1,027 | · | · | 3,083 Direct | -24.99% | Disposed | (price as of 2026-10-02) |
| Sept. 4, 2026 | BIO | A | 4,313 | · | · | 4,313 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2026 | BIO | M | 425 | · | · | 935 Direct | +83.33% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2026 | BIO | F | 154 | $380.96 | $58,668 | 781 Direct | -16.47% | Disposed | -3.1% (price as of 2026-10-02) |
| Sept. 1, 2026 | BIO | M | 174 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2026 | BIO | M | 251 | · | · | 251 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Nov. 6, 2025 | BIO | S | 700 | $306.18 | $214,326 | 510 Direct | -57.85% | Disposed | 20.6% (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 1,056 | · | · | 1,588 Direct | +198.50% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | F | 378 | $295.43 | $111,673 | 1,210 Direct | -23.80% | Disposed | 25.0% (price as of 2026-10-02) |
| Sept. 6, 2025 | BIO | M | 1,056 | · | · | 3,168 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2025 | BIO | A | 4,110 | · | · | 4,110 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2025 | BIO | M | 602 | · | · | 749 Direct | +409.52% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2025 | BIO | F | 217 | $297.88 | $64,640 | 532 Direct | -28.97% | Disposed | 23.9% (price as of 2026-10-02) |
| Sept. 1, 2025 | BIO | M | 178 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2025 | BIO | M | 174 | · | · | 174 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2025 | BIO | M | 250 | · | · | 502 Direct | -33.24% | Disposed | (price as of 2026-10-02) |
| March 3, 2025 | BIO | A | 2,918 | · | · | 2,918 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2024 | BIO | A | 4,224 | · | · | 4,224 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 4, 2024 | BIO | S | 623 | $330.49 | $205,895 | 147 Direct | -80.91% | Disposed | 11.7% (price as of 2026-10-02) |
| Sept. 3, 2024 | BIO | M | 217 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 3, 2024 | BIO | F | 78 | $334.31 | $26,076 | 770 Direct | -9.20% | Disposed | 10.4% (price as of 2026-10-02) |
| Sept. 3, 2024 | BIO | M | 217 | · | · | 848 Direct | +34.39% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2024 | BIO | M | 265 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 2, 2024 | BIO | F | 95 | $337.32 | $32,045 | 631 Direct | -13.09% | Disposed | 9.4% (price as of 2026-10-02) |
| Sept. 2, 2024 | BIO | M | 265 | · | · | 726 Direct | +57.48% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 177 | · | · | 178 Direct | -49.86% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 173 | · | · | 348 Direct | -33.21% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 250 | · | · | 752 Direct | -24.95% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | F | 64 | $337.32 | $21,588 | 461 Direct | -12.19% | Disposed | 9.4% (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 177 | · | · | 525 Direct | +50.86% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | F | 62 | $337.32 | $20,914 | 348 Direct | -15.12% | Disposed | 9.4% (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 173 | · | · | 410 Direct | +73.00% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | F | 90 | $337.32 | $30,359 | 237 Direct | -27.52% | Disposed | 9.4% (price as of 2026-10-02) |
| Sept. 1, 2024 | BIO | M | 250 | · | · | 327 Direct | +324.68% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 6, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,056 | Disposed |
| Sept. 5, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,027 | Disposed |
| Sept. 4, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,313 | Acquired |
| Sept. 1, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 174 | Disposed |
| Sept. 1, 2026 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 251 | Disposed |
| Sept. 6, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,056 | Disposed |
| Sept. 5, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,110 | Acquired |
| Sept. 1, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 178 | Disposed |
| Sept. 1, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 174 | Disposed |
| Sept. 1, 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 250 | Disposed |
| March 3, 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $256.45 | March 3, 2035 | 2,918 | Acquired |
| Sept. 6, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 4,224 | Acquired |
| Sept. 3, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 217 | Disposed |
| Sept. 2, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 265 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 177 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 173 | Disposed |
| Sept. 1, 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 250 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 8, 2024 | BIO | Bio-Rad A Common Stock | 31 | Direct |
| May 8, 2024 | BIO | Restricted Stock Units | 217 | Direct |
| May 8, 2024 | BIO | Restricted Stock Units | 265 | Direct |
| May 8, 2024 | BIO | Restricted Stock Units | 355 | Direct |
| May 8, 2024 | BIO | Restricted Stock Units | 521 | Direct |
| May 8, 2024 | BIO | Restricted Stock Units | 1,002 | Direct |
| May 8, 2024 | BIO | Non-Qualified Stock Option (right to buy) | 1,179 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $536,752 | · | · | · | $266,079 | · | $303,685 | $2,611,227 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.